Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Cystadrops Generic Name & Formulations
Legal Class
Rx
General Description
Cysteamine 0.37%; oph soln; contains benzalkonium chloride.
Pharmacological Class
Cystine-depleting agent.
How Supplied
Soln—5mL
Manufacturer
Generic Availability
NO
Cystadrops Indications
Indications
Treatment of corneal cystine crystal deposits in patients with cystinosis.
Cystadrops Dosage and Administration
Adults and Children
Instill 1 drop in each eye, 4 times a day during waking hours. Discard after 7 days of opening.
Cystadrops Contraindications
Not Applicable
Cystadrops Boxed Warnings
Not Applicable
Cystadrops Warnings/Precautions
Warnings/Precautions
Remove contact lenses prior to application; may be reinserted after 15mins. Pregnancy. Nursing mothers.
Cystadrops Pharmacokinetics
See Literature
Cystadrops Interactions
Interactions
Allow an interval of 10mins between applications with other topical ocular products; administer eye ointments last.
Cystadrops Adverse Reactions
Adverse Reactions
Eye pain, vision blurred, eye irritation, ocular hyperaemia, instillation site discomfort, eye pruritus, lacrimation increased, ocular deposits; possible benign intracranial hypertension.
Cystadrops Clinical Trials
See Literature
Cystadrops Note
Not Applicable
Cystadrops Patient Counseling
See Literature
Images
